Evidence map›Paper›PMID 35502329›Full record

ArticleCancer management and research2022

Clinical Characteristics and Image Manifestations of a Rare Retinoblastoma with a Bone Metastasis.

Huali Gu, Yizhuo Wang, Dongsheng Huang, Xunda Ji, Yi Zhang, Jianmin Ma, Mei Li, Weiling Zhang, Huimin Hu, Jing Li and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Cancer management and research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Huali GuDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China.ORCID 0000-0002-4620-6296
Yizhuo WangDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China.
Dongsheng HuangDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China.
Xunda JiDepartment of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Yi ZhangDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China.
Jianmin MaDepartment of Ophthalmic Oncology, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China.
Mei LiDepartment of Nuclear Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China.
Weiling ZhangDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China.ORCID 0000-0002-0568-1322
Huimin HuDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China.ORCID 0000-0002-0003-4433
Jing LiDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China.
Pinwei ZhangDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China.
Beijing Tongren Hospital · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Retinoblastoma (RB) is the most common intraocular malignancy in infancy and childhood. This study evaluated the clinical and imaging features, treatment, and prognosis of patients with recurrent RB with limb bone metastases and without central nervous system involvement. Patients and Methods: The clinical data of five patients with RB with limb bone metastases who were diagnosed at the Department of Pediatrics in Beijing Tongren Hospital between January 2015 and January 2021 were analyzed retrospectively. Results: Three males and two females were included (seven eyes: four group E and one each of group D, C, and B). The most common symptom was pain. Three patients had bone marrow and lymph node metastases. Three patients had single and two had multiple skeletal lesions. The main bones that were involved were the femur, humerus, talus, and ulna. The simultaneous involvement of the bone marrow and cortex was also observed. Serum neuron-specific enolase (NSE) levels were significantly elevated in four cases and slightly elevated in one case; primary intravenous chemotherapy resulted in a decrease in NSE levels and the gradual resolution of the bone lesions. Two patients died at the time of follow-up and three were in complete remission. The results of the statistical analysis showed that anterior chamber invasion was correlated with prognosis, and there was significant difference in the decrease in the serum NSE levels after intravenous chemotherapy. Conclusion: Regular lifelong follow-up of patients with RB is warranted to identify bone metastases earlier. Anterior chamber invasion may be a risk factor. The simultaneous involvement of the bone marrow and cortex is characteristic manifestations in images of RB with bone metastases. Multidisciplinary treatment especially intravenous chemotherapy is useful, at least at the beginning.

Indexed as

NSEosteoclast inhibitorspamidronatepathological fracturerecurrentSRE

Identifiers

PMID35502329
PMCPMC9056098
OpenAlexW4225016659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.